WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife News Network.

Clinical trial in South Africa to study efficacy of psilocybin on women with HIV and depression

A new study in South Africa aims to examine the effect of psilocybin on treating depression in HIV-positive women with the goal of increasing treatment compliance.

No matter how effective HIV and AIDS treatment have become in the so-called “first world,” the disease is still devastating in places like South Africa. Indeed, HIV infection represents one of the most serious public health challenges in the country. South Africa has the tragic distinction of being the country with the highest number of people infected with the disease globally and the fourth highest adult HIV prevalence rate according to UN statistics. A whopping 13% of the population is infected.

Further the demographics are different than they have been in Western countries. It is not a disease mostly of gay and bisexual men, but straight, Black women. In fact, women are twice as likely to contract HIV in sub-Saharan Africa. Tragically, women between 15-19 years old account for 6 out of 7 new infections and represent 63% of the newly infected. In 2020, 4,200 women between 15 and 24 became infected weekly.

AIDS contributes to about a quarter of all deaths in the country.

Beyond the complications of AIDS, however, are two other large and looming problems.

About one third of all South African HIV patients are also comorbid with tuberculosis. Beyond this, mental illness, specifically major depressive disorder is a widespread and unaddressed problem. According to available data, 40% of South Africans living with HIV also suffer from depression and 60% suffer from PTSD.

e-mail icon
Continue reading

This is what it feels like to have marijuana side effects

 

 

Pay attention to these signs.

Many people find marijuana beneficial, either for recreation or relief from a medical condition. But some people have a less pleasant experience with cannabis. Marijuana can cause side effects, which can range from unpleasant to risky for health. This is what it may feel like to experience some of the most common side effects of marijuana. 

1. You may cough or feel short of breath

Smoking marijuana involves inhaling, well, smoke, and that can irritate your lungs. "Research shows that smoking marijuana causes chronic bronchitis and marijuana smoke has been shown to injure the cell linings of the large airways, which could explain why smoking marijuana leads to symptoms such as chronic cough, phlegm production, wheezing, and acute bronchitis," says the American Lung Association.

 

 

2. You may feel a rapid heartbeat

THC, the main ingredient in marijuana, can raise heart rate by 20 to 50 beats a minute, causing a feeling that your heart is racing. This may last for several hours.

"Marijuana can make the heart beat faster and can make blood pressure higher immediately after use," says the CDC.

"It could also lead to increased risk of stroke, heart disease, and other vascular diseases." Researchers think THC may cause inflammation in blood vessels, damaging them.

e-mail icon
Continue reading

Should healthy people start using cannabis?

Various forms of cannabis can help address the stress and anxiety that prevents us from achieving a mindful state. Here are some other things it does.

With the increasing awareness of the health benefits of cannabis for treating a multitude of ailments, it would be normal for a healthy person to wonder if there are any advantages for them using cannabis.

The truth is that cannabis can still be therapeutic and help even the healthiest of people. You don’t have to be sick or ill to enjoy its health benefits. This plant medicine is extremely powerful for helping mitigate even the most minor occurrences in our daily lives that can build up over time and make us sick — either mentally, emotionally, or physically.

Understanding the endocannabinoid system

Before you get to know how cannabis works in the human body, whether for sick or healthy people, it’s essential to understand the endocannabinoid system (ECS).

As humans, we have another system that biology classes of the past did not teach us about: the endocannabinoid system. This complex system as first identified back in the early 1990’s, and while much of it is still mysterious, experts do know that it’s vital for helping regulate many processes that keep us healthy. These include regulating our appetite, mood, sleep, fertility, reproduction, memory, inflammation, and much more. It does so through the massive network of cellular receptors and chemical signals within the ECS.

Meanwhile, the CB1 and CB2 receptors which can be found in the brain as well as other parts of the body, work to regulate other neurotransmitters. This is how cannabis helps to increase or decrease functions in the body such as sleep or hunger in order to achieve homeostasis. These receptors are further stimulated through endocannabinoids, which are compounds similar to the cannabinoids in the cannabis plant except that our human bodies produce our own. While we have our own endocannabinoids in the body, the cannabinoids in the plant help the endocannabinoid system work more effectively and address even minor ailments to promote balance all throughout.

smoking bong
Continue reading

This year, more Oregon health care providers can recommend medical marijuana for patients

A new law that went into effect in January allows more attending health care providers who have primary responsibility for the care and treatment of a person diagnosed with a debilitating medical condition to recommend medical marijuana to a patient. In May 2021, the Oregon Legislature passed HB 3369, which expanded the definition of attending provider under the rules for the Oregon Medical Marijuana Program (OMMP). After the new year, attending providers allowed to recommend medical marijuana now include:
Doctor of Medicine (MD) or Doctor of Osteopathy (DO), licensed under ORS chapter 677.Physician Assistant licensed under ORS 677.505 to 677.525.Nurse Practitioner licensed under ORS 678.375 to 678.390.Clinical Nurse Specialist licensed under ORS 678.370 and 678.372.Certified Registered Nurse Anesthetist as defined in ORS 678.245.Naturopathic Physician licensed under ORS chapter 685.

Having "primary responsibility” means the attending provider has one of the following roles:

Provides primary health care to the patient.Provides medical specialty care and treatment to the patient.Is a consultant who has been asked to examine and treat the patient by the patient's primary care physician licensed under ORS chapter 677, the patient's physician assistant licensed under ORS chapter 677, or the patient's nurse practitioner licensed under ORS chapter 678.

The provider must also have reviewed a patient's medical records at the patient's request and conducted a thorough physical examination of the patient; provided or planned follow-up care; and documented these activities in the patient's medical record.

To recommend medical marijuana in Oregon, an attending provider must evaluate the patient’s health history, perform a physical examination, and determine that the use of marijuana may mitigate the symptoms or effects of the patient’s debilitating medical condition. Qualifying conditions include:

Cancer, glaucoma, a degenerative or pervasive neurological condition, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, or a side effect related to the treatment of those medical conditions.A medical condition or treatment for a medical condition that produces, for a specific patient, one or more of the following:Cachexia.Severe pain.Severe nausea.Seizures, including but not limited to seizures caused by epilepsy.Persistent muscle spasms, including but not limited to spasms caused by multiple sclerosis.Post-traumatic stress disorder.

An Attending Provider Statement (APS) form must be signed by the attending provider attesting that the patient has been diagnosed with a debilitating medical condition and that the medical use of marijuana may mitigate the symptoms or effect of the individual’s debilitating medical condition. As an alternate, the attending provider may supply the patient with relevant portions of the patient’s medical records containing the same information on the APS.

The patient is responsible for submitting the APS, or relevant medical records, with other required application documents, to the OMMP. The APS or relevant medical documents must be submitted within 90 days of the attending provider’s signature when a patient applies for the first time. When a patient is renewing with OMMP, application material must be submitted within 90 days of their registration card expiration date and the APS must be signed within that 90-day period.

e-mail icon
Continue reading

8 potential benefits of medical marijuana

 

People have argued for over a century about whether the benefits of medicinal marijuana outweigh the risks. Supporters of marijuana as medication claim that it has many potential benefits and can alleviate symptoms more effectively than conventional pharmaceuticals. Risks are low since marijuana is generally effective at low doses. Marijuana also may allow patients to reduce or stop using other pain relievers or medications. Therefore, it is strongly recommended to look into each state’s regulations. If you are interested about the laws in our state you can see here a guide on how to get a medical marijuana card in Maryland, fully online.

Here are eight potential benefits of medicinal marijuana.

 

 

 

1. Reducing inflammation

Researchers have found that THC can suppress inflammatory processes, resulting in less pain. They showed the levels of inflammation in patients with osteoarthritis to be significantly lower after they were treated with THC compared with other analgesics. Patients with rheumatoid arthritis who used marijuana had less swelling, reported less pain, and experienced faster recovery than those who did not use marijuana. In several studies, the anti-inflammatory properties of cannabinoids were effective in treating both arthritis and neuropathic pain.

2. Increase appetite

The FDA has approved a synthetic cannabinoid spray known as dronabinol to increase appetite and manage weight loss in people with AIDS. This drug is sometimes prescribed “off-label” to cancer, glaucoma, and multiple sclerosis patients. Studies have shown that marijuana can be useful in treating anorexia and weight loss in people with cancer, HIV, and other conditions that cause side effects such as nausea or vomiting.

e-mail icon
Continue reading

Does marijuana smoking harm vision? A study reveals how it alters the way you see

Regardless of how you use cannabis, one thing is clear – it can cause both immediate and long-term effects including changes in perception and increased heart rate, to name a few.

To that end, there are two sides to a story. (Benzinga)

While there are studies that confirmed the negative effects of marijuana use, the number of those demonstrating the health benefits of cannabis, especially when used as a treatment for diseases such as cancer, continue to grow.  

Still, every cannabis user must have wondered how to hide those little telltale signs that happen when smoking weed, with one being the most apparent – bloodshot eyes.

Caused by the dilation of the capillaries, due to THC, or the tetrahydrocannabinol binding to cannabinoid receptors, which when activated result in a mild rise in blood pressure and heart rate. Bloodshot eyes can be unpleasant and irritating.

Cannabis & vison

But how does marijuana affect vision in the longer term?

According to a study published in the journal Scientific Reports last year, smoking weed considerably alters vision.

e-mail icon
Continue reading

Former Mississippi Governor enters the medical marijuana industry with testing facility

Former Governor joins healthcare professionals to launch testing facility in new medicalmarijuana program for Mississippi.  

Former Mississippi Governor Ronnie Musgrove will is joining an executive hospital team to form Magnolia Tech Labs. This new business will be a state of the art testing facility service for the state’s new medical marijuana industry.

Beginning yesterday, the Mississippi Department of Health opened applications for growers, dispensaries, and testing facilities to operate in the medical marijuana business. These applications are required to be filed in order to receive certification.

Quentin Whitewell and Dr. Kenneth Williams, as well as a Nashville partner Bappa Mukherji, have developed a comprehensive health care system in underserved areas of the North Delta. Over the years they have developed a friendship with Governor Musgrove leading to the most recent business venture.

“Governor Musgrove’s roots are where we have planted our healthcare flag, and his experience has brought a common bond. We share a passion of helping communities that were losing their hospitals,” said Whitwell.

“Musgrove had been involved in the trade association that helped the get the initiative passed. No one was really talking about safety testing of the product at that time, and we knew that was going to be a very necessary part of the public trust in the industry.”

i
Continue reading

Cancer pain treatment using marijuana safe and effective, large study finds

Scientists have gathered evidence showing cannabis significantly improves the symptoms of cancer patients, with minimal side effects.

In a paper published last week in the journal Frontiers in Pain Research, researchers from Israel stated that cannabis could be a promising alternative to the current standard opioid pain relief offered to cancer patients, which can cause addiction and other negative side effects. Medicinal cannabis use also has side effects, ranging from nausea and weakness to psychosis. However, as the paper says, "the adverse effects from cannabinoids for cancer treatment are generally well tolerated by the patients and categorized as mild to moderate."

Cannabis contains compounds called cannabinoids, which are the active ingredients in both medicinal cannabis and recreational marijuana. THC ((-)-Δ9-trans-tetrahydrocannabinol) is the main psychoactive compound, while CBD (cannabidiol) is non-psychoactive and has long been thought to help with pain relief.

Before this study, the authors state in the paper, research on the use of medicinal cannabis in pain relief was sparse, mostly small-scale studies. However, this paper used a comprehensive and large-scale cohort of 404 patients. In this study, patients were prescribed a dosage of medicinal cannabis by an oncologist, which was administered via two routes: inflorescences (for smoking or inhaling) and/or oil extracts (under the tongue). The initial dose given was 20 grams (0.7 ounces) a month regardless of how it was administered.

Before starting treatment, the patients filled out questionnaires regarding their cancer treatment symptoms, which can include pain, anxiety, depression, insomnia, increased disability, and negative effects on sexuality. At various points during the proceeding six months, the patients would do the questionnaires again, the results of which gave the researchers data on improvements or changes in these symptoms. In the paper, the authors say that most of the studied cancer comorbidities improved significantly during the 6 month period of medicinal cannabis treatment, with total cancer symptoms burden declining by a median of 18 percent, and average weekly pain intensity being reduced by a median of 20 percent. Additionally, they found that the use of medicinal cannabis treatments in cancer patients was "well tolerated and safe", and that over the course of the 6 months, patients did not need to increase their dosages in order for the cannabis to be as effective as it was originally at the beginning of the treatment.

While 40 percent of the patient sample stopped all analgesic medications after the 6 cannabis treatment period, the authors say that 25 percent reported that their pain intensity had increased after stopping the cannabis treatment, with 20 percent of the sample beginning to take analgesics afterwards. One explanation that the authors posit is that those who survived the 6 months of treatment had a less severe disease, and therefore naturally had fewer comorbidities by the end of the study.

e-mail icon
Continue reading

Hemp seed oil skincare products by Vido's Health & Beauty USA will soon be on OneLavi

OneLavi will soon carry Vido’s Health & Beauty USA skincare products that contain Hemp Seed Oil.

“We are thrilled that OneLavi, a boutique health, wellness, and beauty website, will offer our skincare products with HSO to its customers,” said Iva Plummer, one of the co-founders of Vido’s Health & Beauty USA.

“We are launching our products in the U.S. this year, and OneLavi will be one of the first retailers to see our HSO skincare products.”

Plummer said Hemp Seed Oil is perfect for the skin because it moisturizes and reduces inflammation.

“Because of HSO, our skincare products also are rich in anti-oxidants, ‘which can prevent or slow damage to cells caused by free radicals,’” Plummer said.

“Antioxidants help reduce inflammation, which is a common cause for a variety of skin conditions.”

e-mail icon
Continue reading

Review finds cannabis treatment for sleep disorders warrants further investigation

Encouraging outcomes in recent studies have the authors of a recent review calling for more research on the effect of cannabinoids on sleep disorders.

A review published in Nature and Science of Sleep found promising results of cannabinoid medicine on sleep disorders in several studies, which was a sign to the authors that further research to explore this relationship would be helpful in this field.

The review used studies that were taken from PubMed, Web of Science, Google Scholar, and Scopus that were searched between January and February 2022. The review was limited to clinical research, except in cases of obstructive sleep apnea (OSA), narcolepsy, and idiopathic hypersomnia, where preclinical data is used at times.

The effect of cannabinoids on sleep quality is mixed, with the largest and most recent study conducted by Linares, et al, identifying no change in any measure of sleep quantity or architecture when 27 young volunteers took 300 mg dose of cannabidiol (CBD) compared with placebo. No studies that included tetrahydrocannabinol (THC) reported an improvement in time taken to fall asleep (sleep onset latency; SOL), although one reported a reduction in wake time after sleep onset (WASO).

The effect of THC on insomnia has been evaluated in several studies. The earliest published study was a double-blind, randomized controlled study where 9 people were given 10 mg, 20 mg, 30 mg THC or a placebo and self-reported symptoms. SOL decreased by 43 to 62 minutes when taking THC compared with placebo, although there were no differences in number of awakenings or time spent awake. Adverse events occurred more often as dosage of THC increased and more frequent in the evening.

There were 2 other randomized controlled trials that studied synthetic THC (nabilone) on sleep and/or insomnia symptoms. Insomnia symptoms were significantly improved in 29 patients when taking 0.5-1.0mg of nabilone compared with 10-20mg of amitriptyline (insomnia severity index, 3.25 units) for 2 weeks. Nabilone and amitriptyline were both beneficial compared with baseline, but sleep quality was not improved. Adverse events were also more frequent in nabilone compared with amitriptyline (91 vs 53).

e-mail icon
Continue reading

Mississippi medical marijuana application requests start now, huge deal for Magnolia State

 

It may not seem like a big deal to the millions of Americans living in legal cannabis states, but Wednesday is huge for medical marijuana supporters in Mississippi. June 1 is the first day for medical marijuana patients to submit their applications for a card in the Magnolia State. Businesses will also be able to apply for licenses. (Benzinga)

 

Long Time Coming

In February, Republican Gov. Tate Reeves signed legislation into law, making Mississippi the 37th state to legalize medical marijuana. At the time the governor said, "There is no doubt that there are individuals in our state who could do significantly better if they had access to medically prescribed doses of cannabis." 74% of Mississippi voters approved the medical marijuana program. 

At least 28 cities and a dozen counties have completely opted out of the medical marijuana program though, reported Mississippi Today, adding that the state’s health department is not keeping an official list of all the municipalities restricting cannabis businesses.  

Ken Newburger, director of the Mississippi Medical Marijuana Association, said the law itself did not include a directive for municipalities to report. At the same time, the lack of an official list should not embolden anyone to attempt to get around the system, he warned. 

“If you try to open a dispensary in a city that has opted out, the local officials have every power to 1. Stop you and 2. Report you to the state,” Newburger said. 

e-mail icon
Continue reading

Can you ask your doctor for a cannabis prescription instead of painkillers?

Keep in mind that doctors are a wealth of knowledge, but medical marijuana and its benefits are a very new science and not all medical professionals are up to date with the latest developments. 

It is completely understandable to have skepticism towards prescription pain medication. America’s opioid crisis continues to take record numbers of lives, while many others live quietly addicted to pain medication. 

If you injure yourself or require surgery, you are likely going to experience pain. You also might want nothing to do with potentially-addictive pain medication when it is offered. Marijuana, as we have previously reported, can be a great alternative to opioids. But will your doctor prescribe you weed instead of painkillers?

Health care professionals can’t actually prescribe pot because the federal government still classifies marijuana as a schedule 1 drug. In other words, your doctor can’t exactly toss out your opioid prescription and write a new one for medical marijuana. Depending on the state, however, the doctor might be able to assist you in using marijuana as medical therapy for your recovery. The bigger question is, is your doctor willing to sign off on this?

Be honest with your physician

There is no point in beating around the bush, or trying to deceive your doctor. They have seen it all, and can spot a liar. If you want marijuana instead of other pain medication, just plead your case.

The current opioid crisis in the country is not a secret. A physician is likely going to be far more receptive to a patient who is honest about not wanting to use opioids, but instead prefers the marijuana route. If you are afraid of the dangers of opioids, or their adverse side effects – be vocal. This won’t guarantee you a medical marijuana card, but it opens up a dialogue to alternative treatments.

e-mail icon
Continue reading

Clinical studies support Charlotte's Web CBD Clinic™ topicals as safe for massage and frequent use

Leading Massage Franchise Appoints New Chief Financial Officer and Vice President of Studies indicate CBD Clinic™ hemp topicals for massage do not irritate, or penetrate into the bloodstream, after high-frequency, repeated use such as in massage therapy

Charlotte’s Web Holdings, Inc. (“Charlotte’s Web,” “CW” or the “Company”), the market leader in full-spectrum hemp extract CBD products, today announced results from a series of clinical research studies on frequent use of Charlotte’s Web CBD Clinic™ branded topicals in regular and hot stone massage.

The studies included:
Clinical Safety Testing (CBD Clinic™ Relax Massage Cream) – Repeated Insult Patch testClinical Safety Testing (CBD Clinic™ Relax Massage Cream) – A five-week 60 subject clinical study

The research found that high-frequency repeated use, typical with massage therapists, of Charlotte’s Web CBD Clinic™ massage products did not lead to systemic absorption of cannabinoid metabolites in the bloodstream, nor did the products cause skin irritation.

An expert opinion paper was prepared based on the studies’ findings [“Expert Opinion on the Safety Profile of CW Full-Spectrum Hemp Extract in the Practice of Massage Therapy”]. The opinion paper was conducted by third-party clinical research organizations, Charlottes Web’s CW Labs division, and a comprehensive literature review. The paper was prepared by Dr. Sherry Bradford, Ph.D. Biochemistry. Dr. Bradford is a former faculty member of University at Buffalo and an editorial board member of The Scientific Federation of Oncology and Cancer (Editor in Chief) and the Journal of Biomolecular Research and Therapy. In the opinion paper, Dr. Bradford found:

“The scientific data and research performed on the safety and skin permeation of Charlotte’s Web CBD Clinic™ hemp topical products support safe repeated use by MTs [massage therapists], for massage clients, and in normal (heat generated from friction only) and hot stone (additional heat applied) massages.”

Charlotte’s Web, a certified B Corporation, is committed to building a responsible, science-driven and transparent industry for those seeking access to safe, high-quality hemp wellness products. These clinical studies are among many formal scientific investigations supported by the Company’s CW Labs division.


Continue reading

Study finds THC detected in blood or breath does not indicate impairment

A recently published study has revealed that THC levels in blood or breath do not correlate to impairment or the time of last cannabis use.

A new study published this month adds further evidence that levels of THC detected in the blood or breath of cannabis users is not a reliable indicator of impairment. Researchers also found that levels of THC in blood and breath did not provide reliable evidence of how recently a test subject had used cannabis.

In their introduction to the study, the researchers noted that “finding an objective measure of recent cannabis use that correlates with impairment has proven to be an elusive goal.” Some states have enacted laws that set per se legal limits on the amount of THC a driver may have in their blood, similar to the 0.08% blood alcohol concentration limit in effect nationwide.

Critics of per se limits on THC concentrations in blood or breath have argued that such limits have little bearing on the level of impairment or intoxication, which can vary widely from person to person despite similar levels of THC concentration.

“These findings provide further evidence that single measurements of specific delta-9-THC blood concentrations do not correlate with impairment, and that the use of per se legal limits for delta-9-THC is not scientifically justifiable at the present time,” wrote the authors of the study published by the journal Scientific Reports.

To conduct the study, the researchers recruited a group of test subjects, most of whom were daily cannabis users. The scientists then determined the THC levels in their blood and breath prior to and after inhaling cannabis.

e-mail icon
Continue reading

Why weed is the drug of choice for today’s young adults

For now, it seems that cannabis will be growing in market share over the coming years and the next generations will consume it far more openly than previous generations.

It turns out that the youths of today are far more interested in consuming cannabis as they are smoking tobacco and drinking alcohol. While some might think this is bad news, it is in fact much better news than you could anticipate.

A recent study, published int the Journal of Adolescent Health, revealed the following (via NORML): Researchers with the University of Washington assessed trends in alcohol, nicotine, and non-prescribed pain reliever use among a cohort of over 12,500 young adults (ages 18 to 25) in Washington State following adult-use cannabis legalization.

They reported, “Contrary to concerns about spillover effects, implementation of legalized non-medical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse.” Researchers did find that the prevalence of past-month e-cigarette use increased post-legalization.

Authors concluded, “Our findings add to evidence that the legalization of non-medical cannabis has not led to dramatic increases in the use of alcohol, cigarettes, and non-prescribed opioids. … The findings indicate that the most critical public health concerns surrounding cannabis legalization and the evolution of legalized cannabis markets may be specific to cannabis use and related consequences.”

Commenting on the study’s findings, NORML’s Deputy Director Paul Armentano said: “Real-world data from legalization states disputes longstanding claims that cannabis is some sort of ‘gateway’ substance. In fact, in many instances, cannabis regulation is associated with the decreased use of other substances, including many prescription medications.”  

social
Continue reading

Surprising side effects of marijuana after age 50

Although marijuana has been typically associated with younger adults, that is a stereotype according to the National Library of Medicine. People over 50 are using the drug more often now.

"As an older population grows in the United States that has a tolerant attitude toward marijuana use, the dynamics of marijuana use and the effects of marijuana on personal, social, and health outcomes among older adults require attention," the site states. And according to a study published in the International Journal of Drug Policy, marijuana use in people over 65 increased by 75 percent between 2015 and 2018. That said, while marijuana does provide a lot of medicinal benefits, it does affect everyone differently and experts reveal it can cause unexpected side effects. Read on—and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

1. Why more older people are using marijuana

 

Chaye McIntosh, Clinical Director, ChoicePoint says, "Aging is a major factor linked to metabolic changes, various morbidities, increased prescription drug usage, and a general loss in functioning. In recent years, the usage of marijuana for recreational and medical purposes among older individuals has expanded dramatically to reduce the visible and non-visible effects of aging."
 
 

2. Cannabinoid Hyperemesis Syndrome (CHS)

McIntosh shares, "Long-term cannabis usage causes CHS, which is characterized by severe cyclical nausea and vomiting, as well as epigastric or periumbilical abdomen discomfort. It goes unnoticed due to a lack of awareness. The prevalence rate is around 95% among users."

Cedars Sinai states, "Marijuana has very complex effects on the body. Experts are still trying to learn exactly how it causes CHS in some people. In the brain, marijuana often has the opposite effect of CHS. It helps prevent nausea and vomiting. The drug is also good at stopping such symptoms in people having chemotherapy. But in the digestive tract, marijuana seems to have the opposite effect. It actually makes you more likely to have nausea and vomiting. With the first use of marijuana, the signals from the brain may be more important. That may lead to anti-nausea effects at first. But with repeated use of marijuana, certain receptors in the brain may stop responding to the drug in the same way. That may cause the repeated bouts of vomiting found in people with CHS. It still isn't clear why some heavy marijuana users get the syndrome, but others don't."

3. Psychosis

According to McIntosh, "Chronic users are at high risk of developing chronic psychosis disorders like schizophrenia. It causes hallucinations and personality disorders in 95% of users."

Cannabis plant
Continue reading

Cannabis and autism: What to know

Some small studies and anecdotal sources suggest that autistic people may benefit from the therapeutic effects of cannabis. However, there is currently not enough evidence to support this claim.

The brains of autistic people and people who do not have autism spectrum disorder (ASD) develop differently. As a result, autistic people may behave, interact, and learn differently from people without ASD.

Having ASD may lead to repetitive patterns of behavior and some difficulties in social interactions. ASD also sometimesTrusted Source causes delayed language development, hyperactivity, seizures, and gastrointestinal problems.

Medications can address some symptoms of ASD. Also, if ASD symptoms have negative effects on the quality of life, a person might consider trying medicinal cannabis.

Keep reading to learn more about ASD and cannabis use, including the risks, possible benefits, and some other alternative ways of reducing certain symptoms.

 

e-mail icon
Continue reading

Medical cannabis provides little improvement to sleep in chronic pain patients

Sleep disorders affect a sizeable portion of the general population, with cannabis increasingly being studied as a component of therapy for improved sleep. Previous studies have showed a large percentage of cannabis users purchase cannabis for sleep disorders. This study addressed the lack of meta-analyses on the effect of medical cannabis and cannabinoids on impaired sleep.

This systematic review and meta-analyses of randomized controlled trials (RCTs) evaluated the effect of medical cannabis or cannabinoids on sleep. Inclusion criteria includes:

1) Patients aged 18 or older with impaired sleep

2) RCTs that compared medical cannabis to a non-cannabis control

3) Studies that collected outcome data greater than 13 days after treatment. Open-label trials and studies with patients using cannabis for recreational purposes were excluded. Study outcomes assessed measures such as effect on sleep quality, sleep disturbance, other sleep-related outcomes, and adverse events.

e-mail icon
Continue reading

How much cannabis is necessary to help reduce anxiety? One Florida researcher intends to find out

Using cannabis to curb certain disorders such as social anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, panic disorder and depression is not a novelty.

With the increasing impact of anxiety disorders on family life and the economy, the number of those turning to cannabis as a solution is on the rise. (Benzinga)

Moreover, years of research have proved that cannabis has powerful anxiolytic (anti-anxiety) properties. A study conducted in 2018, by Washington State University researchers, published in the Journal of Affective Disorders, found that a single puff of cannabis high in CBD and low in THC was enough to reduce depression symptoms. After two puffs, patients felt less anxious, and after ten they were less stressed.

When states legalize recreational cannabis, the volume of prescriptions for drugs that treat an array of such medical conditions significantly declines, a Cornell research team recently revealed.

While more research on the subject is never a bad thing and keeping in mind that cannabis affects different people in different ways, it is becoming more evident that marijuana is shedding its stigma.

Study to reveal how much marijuana is needed to reduce anxiety

Now that we’ve established that cannabis is a weapon of choice for some who are struggling with anxiety, the question arises: how much should one consume?

e-mail icon
Continue reading

How much cannabis is necessary to help reduce anxiety? One Florida researcher intends to find out

Using cannabis to curb certain disorders such as social anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, panic disorder and depression is not a novelty.

With the increasing impact of anxiety disorders on family life and the economy, the number of those turning to cannabis as a solution is on the rise.

Moreover, years of research have proved that cannabis has powerful anxiolytic (anti-anxiety) properties. A study conducted in 2018, by Washington State University researchers, published in the Journal of Affective Disorders, found that a single puff of cannabis high in CBD and low in THC was enough to reduce depression symptoms. After two puffs, patients felt less anxious, and after ten they were less stressed.

When states legalize recreational cannabis, the volume of prescriptions for drugs that treat an array of such medical conditions significantly declines, a Cornell research team recently revealed.

While more research on the subject is never a bad thing and keeping in mind that cannabis affects different people in different ways, it is becoming more evident that marijuana is shedding its stigma. (Benzinga)

Study to reveal how much marijuana is needed to reduce anxiety

Now that we’ve established that cannabis is a weapon of choice for some who are struggling with anxiety, the question arises: how much should one consume?

e-mail icon
Continue reading

WeedLife.com